Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES NEULAND LABS DIVIS LABORATORIES/
NEULAND LABS
 
P/E (TTM) x 31.7 26.9 117.9% View Chart
P/BV x 8.4 2.1 403.4% View Chart
Dividend Yield % 0.8 0.4 220.5%  

Financials

 DIVIS LABORATORIES   NEULAND LABS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
NEULAND LABS
Mar-22
DIVIS LABORATORIES/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs5,4252,840 191.0%   
Low Rs3,5621,000 356.2%   
Sales per share (Unadj.) Rs337.5741.3 45.5%  
Earnings per share (Unadj.) Rs111.549.7 224.2%  
Cash flow per share (Unadj.) Rs123.388.0 140.1%  
Dividends per share (Unadj.) Rs30.005.00 600.0%  
Avg Dividend yield %0.70.3 256.4%  
Book value per share (Unadj.) Rs441.8655.1 67.4%  
Shares outstanding (eoy) m265.4712.83 2,069.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.32.6 514.0%   
Avg P/E ratio x40.338.6 104.4%  
P/CF ratio (eoy) x36.521.8 167.0%  
Price / Book Value ratio x10.22.9 347.0%  
Dividend payout %26.910.1 267.6%   
Avg Mkt Cap Rs m1,192,89024,633 4,842.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4621,825 518.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,5989,511 942.1%  
Other income Rs m1,15921 5,580.2%   
Total revenues Rs m90,7579,532 952.2%   
Gross profit Rs m38,8111,426 2,721.3%  
Depreciation Rs m3,115490 635.2%   
Interest Rs m20135 14.8%   
Profit before tax Rs m36,835822 4,483.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,231183 3,942.3%   
Profit after tax Rs m29,605638 4,638.6%  
Gross profit margin %43.315.0 288.9%  
Effective tax rate %19.622.3 87.9%   
Net profit margin %33.06.7 492.4%  
BALANCE SHEET DATA
Current assets Rs m96,1045,828 1,649.1%   
Current liabilities Rs m24,5443,632 675.9%   
Net working cap to sales %79.923.1 345.9%  
Current ratio x3.91.6 244.0%  
Inventory Days Days914 63.1%  
Debtors Days Days987899 109.8%  
Net fixed assets Rs m50,0878,007 625.5%   
Share capital Rs m531129 411.5%   
"Free" reserves Rs m116,7518,276 1,410.7%   
Net worth Rs m117,2828,405 1,395.4%   
Long term debt Rs m01,042 0.0%   
Total assets Rs m146,19113,835 1,056.7%  
Interest coverage x1,842.87.1 25,996.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.7 89.2%   
Return on assets %20.35.6 362.6%  
Return on equity %25.27.6 332.4%  
Return on capital %31.410.1 310.4%  
Exports to sales %072.1 0.0%   
Imports to sales %19.717.0 116.3%   
Exports (fob) Rs mNA6,858 0.0%   
Imports (cif) Rs m17,6761,613 1,096.0%   
Fx inflow Rs m78,4456,858 1,143.9%   
Fx outflow Rs m17,9531,613 1,113.2%   
Net fx Rs m60,4925,245 1,153.3%   
CASH FLOW
From Operations Rs m19,118586 3,263.5%  
From Investments Rs m-21,949-937 2,342.3%  
From Financial Activity Rs m-5,324377 -1,411.5%  
Net Cashflow Rs m-8,15627 -30,706.3%  

Share Holding

Indian Promoters % 51.9 36.2 143.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.5 23.8 153.1%  
FIIs % 16.5 17.4 95.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 63.8 75.4%  
Shareholders   346,905 31,976 1,084.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


More on Divis Laboratories vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs NEULAND LABS Share Price Performance

Period Divis Laboratories NEULAND LABS S&P BSE HEALTHCARE
1-Day 0.33% 5.31% 0.64%
1-Month 2.23% 7.34% 1.39%
1-Year -22.77% -12.21% -10.57%
3-Year CAGR 30.57% 39.56% 23.15%
5-Year CAGR 34.05% 7.06% 11.47%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of NEULAND LABS the stake stands at 36.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

NEULAND LABS paid Rs 5.0, and its dividend payout ratio stood at 10.1%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.